Skip to Main Content

2020 Spencer Stuart Healthcare Sector Snapshot

Governance structures and practices of boards of healthcare companies in the S&P 500 index — a universe of 59 companies — are similar to S&P 500 boards.

  • The average age of independent directors on healthcare boards is 63.3, slightly higher than the S&P 500 average of 63.0.
  • The youngest average age of a healthcare board is 58.4 years and the oldest is 70.3.
  • Healthcare boards average 10.4 members, slightly below the 10.7 director average for S&P 500 company boards.
  • Independent directors represent 86% of all directors on healthcare boards, compared to the 85% average for the S&P 500 universe.
  • The average tenure of independent directors on healthcare boards is 8.0 years, just above the S&P 500 average of 7.9 years.
  • The longest-tenured healthcare board is 15.2 years.

Diversity

Gender diversity of healthcare boards slightly outpaces the S&P 500 universe, with women representing 29% of all healthcare board members in 2020, compared to 28% of S&P 500 directors.

Every S&P 500 company has at least one female director. Ninety-five percent (95%) of the S&P 500 index have at least two female directors, and two-thirds (67%) of S&P 500 companies have three or more female directors. In contrast, all of the companies in the healthcare sector have at least two female directors, and, consistent with the S&P 500, two-thirds (67%) have three or more women. Thirteen S&P 500 boards are composed of at least 50% women; no healthcare boards are composed of at least 50% women.

Representation of Women Directors on Healthcare Boards

When it comes to race/ethnic diversity of the boardroom, 20% of the directors of the 25 healthcare companies in the top 200 companies are minorities (defined as Black/African American, Hispanic/Latinx and Asian), equal to the 20% average for the S&P 500 index. The diversity breakdown of healthcare is consistent with the S&P 500: 12% Black/African American (compared to 10% of S&P 500 directors); 4% Hispanic/Latinx (compared to 4% S&P 500); and 5% Asian (compared to 5% S&P 500). According to the U.S. Census Bureau, about 40% of the U.S. population is estimated to be a minority, including 18.5% Hispanic/Latinx, 13.4% Black/African American, 5.9% Asian.

New independent director backgrounds

Thirty-three healthcare companies — 56% of the surveyed group — added at least one director over the past year. Appointees averaged 57.6 years of age, in line with the 57.8 average for all independent directors joining S&P 500 boards. First-time directors represented 27% of directors joining healthcare boards in 2020 — slightly lower than the 28% overall average for the S&P 500.

Healthcare companies appear to be prioritizing gender diversity with their director appointments. Diverse directors constituted 63% of the 49 directors joining healthcare boards over the past year: 51% are women and 12% are minority men. In comparison 59% of directors joining the S&P 500 index are diverse, including 47% women and 12% minority men.

The healthcare sector also appears to be prioritizing active executives, with 65% of the incoming class actively employed, the highest percentage of all S&P 500 primary sectors. In contrast, 49% of the incoming class of independent directors joining S&P 500 boards are active executives.

In 2020, healthcare companies appointed the highest percentage of academics and “other” professionals of all S&P 500 primary sectors. Compared to the S&P 500 incoming class, fewer independent directors joining healthcare boards over the past year have executive experience (CEO, functional or divisional leadership) or financial experience. The percentage of the sector’s incoming class with financial backgrounds (18%) is the second lowest of all S&P 500 primary sectors. Most (88%) independent directors joining healthcare boards in 2020 are current or former CEOs (24%); finance management/CFO/treasurers (18%); others (18%); academics (16%); and functional unit heads (12%).

2020 Healthcare 2020 S&P 500
CEOs24%29%
Active14%13%
Retired10%16%
Chairs / presidents / COOs6%6%
Active2%3%
Retired4%3%
Line and functional leaders12%16%
Division / subsidiary presidents2%7%
Finance / accounting executives18%27%
Financial executives / CFOs / treasurers14%14%
Investment managers / investors0%8%
Bankers / investment bankers2%4%
Public accounting executives2%1%
Academics / nonprofit executives16%3%
Consultants2%3%
Legal 0%2%
General counsel0%2%
Lawyers0%0%
Others18%7%
Government / military8%5%
Others10%2%

Board leadership

Just over half (54%) of healthcare companies in the S&P 500 index separate the chair and CEO roles, slightly below the 55% average for the S&P 500 index. Independent chairs are in place at 39% of healthcare companies, slightly higher than the 34% of the S&P 500 index and the second highest of S&P primary sectors. Seventy-one percent (71%) of all healthcare companies have an independent lead or presiding director, versus 73% of the S&P 500.

Board organization and process

As detailed below, the healthcare sector’s governance processes and structures generally closely mirror those of the S&P 500 index. One difference is the prevalence of mandatory retirement policies. While 70% of S&P 500 boards have adopted mandatory retirement policies, only 63% of healthcare sector companies have adopted age limits for directors. Another difference is director terms; 20% of healthcare companies have staggered, three-year terms for directors, the highest percentage of all S&P 500 primary sectors. In contrast, only 10% of all S&P 500 companies have classified boards.

2020 Healthcare 2020 S&P 500
Classified board20%10%
Board meetings (avg #)7.87.9
Board committees (avg #)4.34.2
Audit committee
Size (avg #)4.14.4
Meetings (avg #)98.2
Compensation committee
Size (avg #)44.3
Meetings (avg #)6.15.9
Nominating / governance committee
Size (avg #)4.24.4
Meetings (avg #)4.54.5
Mandatory retirement63%70%
Retirement age (avg)73.873.6

Editor's note: Data in tables and charts may not total 100% due to rounding.
 

Healthcare Sector Companies

Abbott Laboratories
AbbVie
ABIOMED
Agilent Technologies
Alexion Pharmaceuticals
Align Technology
AmerisourceBergen Corporation
Amgen
Anthem
Baxter International
Biogen Idec
Boston Scientific Corporation
Bristol-Myers Squibb Company
Cardinal Health
Centene Corporation
Cerner Corporation
Cigna Corporation
CVS Health Corporation
Danaher Corporation
DaVita
Dentsply Sirona
DexCom
Edwards Lifesciences Corporation
Eli Lilly & Company
Gilead Sciences
HCA Healthcare
Henry Schein
Hologic
Humana
IDEXX Laboratories
Illumina
Incyte Corporation
Intuitive Surgical
IQVIA Holdings
Johnson & Johnson
Laboratory Corporation of America Holdings
McKesson Corporation
Medtronic
Merck & Co.
Mettler-Toledo International
Mylan N.V.
PerkinElmer
Perrigo Company
Pfizer
Quest Diagnostics
Regeneron Pharmaceuticals
ResMed
STERIS plc
Stryker Corporation
Teleflex
The Cooper Companies
Thermo Fisher Scientific
UnitedHealth Group
Universal Health Services
Varian Medical Systems
Vertex Pharmaceuticals
Waters Corporation
Zimmer Biomet Holdings
Zoetis